Skip to main content

MS news

Our news web pages include ground-breaking multiple sclerosis news and research from around the world. 

These news stories are taken from external sources and as such, MS-UK does not verify, endorse or accept responsibility for their content.

Some of these pages have been written for medical professionals and this can be reflected in the complexity of language and content.

Supporting you

We’re here to support you, whether you are awaiting a diagnosis of multiple sclerosis or have been living with the condition for years. 

Find out more about the MS-UK Helpline

Find out more about our Choices booklets

Find out more about New Pathways magazine

 


Multiple sclerosis patients in progressive stages of the disease appear to gain some benefit if they take a regimen that includes the antidepressant fluoxetine, researchers suggested at a session of...
A blood test that checks for markers of damaging brain activity may give doctors a way to diagnose how well drugs are working in patients with multiple sclerosis (MS), researchers said at the...
The drug has already shown positive Phase II trial results for people with relapsing-remitting MS (RRMS), and now researchers have presented results of their evaluation of a Phase III trial for SPMS...
Exploratory analyses reinforced findings from three phase 3 studies of ocrelizumab (Ocrevus) in relapsing multiple sclerosis (RMS) and primary progressive multiple sclerosis (PPMS). The findings...
At the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) 2016 Congress in London, researchers shared their views on bone marrow transplants for relapsing forms of multiple...
Children with MS or other demyelinating conditions experience psychiatric disorders more often than other children, a new study has claimed. Data from the study was presented at the European...
A new post-hoc analysis from the pivotal DECIDE study reportedly shows a significantly greater number of people treated with Zinbryta achieved no evidence of disease activity (NEDA) compared to those...
Researchers at the Research Center for Immunotherapy and the Focus Program Translational Neurosciences f Johannes Gutenberg University Mainz have identified a new mechanism that is involved in the...
Scientists believe they have found significant differences in income that correlate with levels of MS-cognitive deficit. These findings were presented at the 32nd Congress of the European Committee...
Multiple sclerosis care and research is lagging behind in the Middle East compared to countries in Europe and North America, according to research presented at the European Committee for Treatment...

Pages